Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Immix Biopharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +6 vs. Q1 2023
- Shares held
- 656.1K
- +255.3K (+63.7%) vs. Q1 2023
- Total value
- $1.75M
- +$1.02M (+139.4%) vs. Q1 2023
- New holders
- 9
- 1 more added
- Sold out
- 3
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 200,250 | $538.7K | 0.68% | +200,250 | New |
| Vanguard Group Inc | 105,357 | $283.4K | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 72,639 | $195.4K | 0.00% | −26,661−26.8% | Reduced |
| Geode Capital Management, LLC | 60,326 | $162.3K | 0.00% | −19,396−24.3% | Reduced |
| Koshinski Asset Management, Inc. | 51,001 | $137.2K | 0.01% | +51,001 | New |
| State Street Corp | 42,960 | $115.6K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 22,825 | $61.0K | 0.00% | +22,825 | New |
| Moss Adams Wealth Advisors LLC | 20,000 | $53.8K | 0.02% | −78−0.4% | Reduced |
| InterOcean Capital Group, LLC | 15,900 | $42.8K | 0.00% | 00.0% | Unchanged |
| Imprint Wealth LLC | 22,280 | $42.3K | 0.03% | +22,280 | New |
| BlackRock Inc. | 15,648 | $42.1K | 0.00% | +15,648 | New |
| Dimensional Fund Advisors LP | 11,911 | $32.0K | 0.00% | +11,911 | New |
| Renaissance Technologies LLC | 10,600 | $29.0K | 0.00% | +10,600 | New |
| Parallel Advisors, LLC | 2,890 | $7.77K | 0.00% | +2,890 | New |
| Tortoise Investment Management, LLC | 1,000 | $2.69K | 0.00% | +1,000 | New |
| Advisor Group Holdings, Inc. | 350 | $941 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 120 | $323 | 0.00% | −6,255−98.1% | Reduced |
| Wells Fargo & Company | 42 | $113 | 0.00% | +4+10.5% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,723−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,692−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,301−100.0% | Sold out |